Ailawadi, S., Murphy, J. E., Storandt, M. H., Rao, R., Mahipal, A. (2026). Comparative clinical outcomes with lenvatinib versus cabozantinib post-progression on first-line immunotherapy in patients with advanced hepatocellular carcinoma.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.e16246